Gefitinib A Firstline treatment of metastatic nonsmall cell lung cancer
03/02/2022 Alternative Treatments
Price: Check with seller
Description
Gefitinib is a kinase inhibitor that is used in giving first-line treatment to patients with metastatic non-small cell lung cancer whose tumors have epidermal growth factor receptor exon 19 deletions or exon 21 (L858R) substitution mutations. This drug is supplied in 250 mg tablets for oral administration. The active ingredient in the medicine is Gefitinib, and the inactive ingredients are lactose monohydrate, microcrystalline cellulose, croscarmellose sodium, povidone, sodium lauryl sulfate and magnesium stearate. This drug reversibly inhibits the kinase activity.
Gefitinib 250 mg price is reasonable in India, and one can readily find this medicine among trusted and certified suppliers. For further information, ring us on 18008891064.
Comments
More Details